Dr EBERST Lauriane

Fiche personne


coordonnées

ICANS | Institut cancérologie Strasbourg Europe
17 rue Albert Calmette
BP 23025
67033 STRASBOURG

03 68 76 66 66

l.eberst@icans.eu

Territoire

Alsace

Statut

Hospitalier

équipes/plateformes

Equipe Oncologie médicale

Recherche

Expertises :
- Clinique:Oncologie Médicale
- Clinique:Gynécologie

Publications


Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?

Sabah J, Menoux I, Eberst L, Lodi M, Gantzer J, Azais H, El Hajj H, Balaya V, Babin G, Espenel S, Dabi Y, Kissel M, Phuong Lien T, Angeles MA, Margueritte F, Deluche E, Marouk A, Le Borgne P, Apithy MS, Laas-Faron E, Akladios C, Lecointre L,

Eur J Surg Oncol. 2024 03 29;50(6):108281

Xevinapant combined with pembrolizumab in patients with advanced, pretreated colorectal and pancreatic cancer: results of the phase 1b/2 CATRIPCA trial.

Voisin A, Terret C, Schiffler C, Bidaux AS, Vanacker H, Perrin-Niquet M, Barbery M, Vinceneux A, Eberst L, Stephan P, Garin G, Spaggiari D, Pérol D, Grinberg-Bleyer Y, Cassier PA

Clin Cancer Res. 2024 03 19;:

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

Voissière A, Gomez-Roca C, Chabaud S, Rodriguez C, Nkodia A, Berthet J, Montane L, Bidaux AS, Treilleux I, Eberst L, Terret C, Korakis I, Garin G, Pérol D, Delord JP, Caux C, Dubois B, Ménétrier-Caux C, Bendriss-Vermare N, Cassier PA

Sci Transl Med. 2024 01 24;16(731):eadd1834

Voir plus